Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan

Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan

Metastatic breast cancer is an incurable form of breast cancer that exhibits high levels of epithelial-mesenchymal transition (EMT) markers. Angiotensin II has been linked to various signaling pathways involved in tumor cell growth and metastasis. The aim of this study is to investigate, for the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Rania Alaaeldin, Fares E. M. Ali, Amany Abdlrehim Bekhit, Qing-Li Zhao, Moustafa Fathy
Formato: Artículo
Lenguaje:English
Publicado: MDPI AG 2022-11-01
Colección:Molecules
Materias:
azilsartan
breast cancer
NF-kB
EMT
IL-6/JAK2/STAT3
SLUG
Acceso en línea:https://www.mdpi.com/1420-3049/27/22/7825

Internet

https://www.mdpi.com/1420-3049/27/22/7825

Ejemplares similares